Log In
Print
BCIQ
Print
Print this Print this
 

Enurev Breezhaler, Seebri Breezhaler, Tovanor Breezhaler, glycopyrronium bromide (NVA237) (formerly AD 237)

  Manage Alerts
Collapse Summary General Information
Company Sosei Group Corp.
DescriptionInhaled long-acting muscarinic antagonist (LAMA)
Molecular Target Muscarinic receptor
Mechanism of ActionMuscarinic receptor antagonist
Latest Stage of DevelopmentMarketed
IndicationChronic obstructive pulmonary disease (COPD)
Partner

Novartis AG; Vectura Group plc
 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today